Proacta's Convertible Note Round

Proacta raised a round of funding on December 23, 2011.

Proacta is a clinical-stage, biopharmaceutical company focused on addressing unmet needs in the field of cancer with current efforts directed towards the development of hypoxia-activated prodrugs that…

Articles about Proacta's Convertible Note Round: